Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for th

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, ha

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Techno

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a c

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil)

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate o